CoreAge Rx offers an online route to a clinical evaluation for compounded NAD+. Its public materials describe both an injectable product and a nasal spray. That makes it a useful starting point for someone comparing a home prescription with repeat visits to an infusion clinic.
CoreAge Rx is our featured commercial partner and appears first in our best-of lists by placement policy. This review is based on public product and offer pages checked September 18, 2026. We have not purchased the treatment, tested a vial, verified individual patient outcomes, or independently inspected a dispensing pharmacy.
A convenient option to investigate, with a visible price discrepancy to resolve. Featured placement reflects our commercial policy, not proven medical superiority.
The supplied offer page shows $99/month; the main product page shows a different $93/month starting price. Confirm your selected plan.
Our assessment
The attraction is practical: an online intake and the possibility of home delivery if a clinician decides a prescription is appropriate. This can reduce the travel involved in seeking care, but it does not establish that treatment is necessary or effective for you. A convenient service should still give you time to ask questions before you commit.
Start with the concern you want evaluated, rather than choosing a drug and fitting a symptom to it. Persistent tiredness, a recent change in concentration, or reduced exercise tolerance deserves a clinical discussion. A prescription decision should consider your history, other medicines, and reasonable alternatives. Our first-appointment checklist helps organize that conversation.
The price discrepancy worth noticing
On our check, the linked offer displayed $99 per month, while the separate injectable product page advertised a starting price of $93 per month. Those are provider statements from different pages, not two prices we have independently obtained at checkout. We use the offer-page figure when describing the link on this site.
Ask for the amount charged today, the quantity supplied, the renewal amount, and the timing of the next charge. If a lower monthly equivalent requires several months paid in advance, compare the full commitment. A prescription can also differ in concentration and usable life, so the lowest displayed monthly number is not automatically the best value.
Injection and nasal spray are separate decisions
The product materials describe NAD+ injection and nasal delivery. A needle-free route may sound more comfortable, but convenience does not prove equal absorption, equal benefit, or equal safety. Do not substitute a spray for an injection or translate a dose between routes yourself.
The public product page is an introduction. The prescription and dispensing label need to identify your actual preparation, concentration, route, directions, storage, and beyond-use date. Confirm whether the quoted plan is for injection or spray before entering payment details. Our route comparison explains what changes when the delivery method changes.
What the clinical evidence can tell you
NAD+ is involved in normal cellular metabolism. That biological role explains scientific interest, but it does not prove that this finished compounded product will improve energy, memory, recovery, or lifespan. The human research we reviewed includes a small IV metabolite pilot and a later retrospective IV tolerability study. Neither is a controlled effectiveness trial of CoreAge Rx home injections or nasal spray.
Provider testimonials can describe an individual experience without separating treatment effects from expectations, other changes, or natural variation. We do not convert testimonials into a success rate. Read our benefits and evidence guide for the distinction between a laboratory marker and a meaningful improvement in daily life.
Pharmacy and support details to obtain
Before a prescription ships, request the dispensing pharmacy’s name and a way to contact its pharmacist. Ask about handling a delivery that arrives warm, damaged, late, or with missing supplies. Find out how to reach clinical support between refills and what the process is for reporting a suspected reaction.
Compounded medicines are not FDA-approved. A statement about a US pharmacy, laboratory testing, or a licensed clinician should not be read as FDA approval of the finished product. The FDA’s sterile-compounding notice makes ingredient suitability and endotoxin control relevant questions for any injectable supplier. Our compounding guide explains the checks without suggesting that a website can certify a vial.
Before starting or renewing
Save the offer terms and prescription instructions for the plan you actually choose. Clarify what happens if treatment is declined, canceled before dispensing, or stopped after a shipment. A refund when a clinician does not prescribe is different from a refund after medication has been prepared.
Agree on a follow-up date and what would count as a useful outcome. If nothing meaningful improves, a renewal should be a deliberate decision. You can compare the membership model in our Hone review, the published product details in our IVY RX review, and nearby search areas in the location directory.
Related questions before an evaluation.
Review home-injection responsibilities, dosing-label questions, and how to assess results before committing to a program. If you are comparing with a store-bought option, oral supplements have different ingredients, evidence, and costs.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- CoreAge Rx: current NAD+ offer Provider advertising; offer page displays $99/month. Checked September 18, 2026.
- CoreAge Rx: NAD+ Injectable product page Provider advertising; product page displays a different starting price of $93/month.
- CoreAge Rx: NAD+ Nasal Provider description of a different administration route.
- FDA: ingredients suitable for sterile compounding Safety notice describing reported reactions and ingredient-quality concerns.
- FDA: compounding questions and answers Explains that compounded drugs are not FDA-approved.
- Grant et al. (2019): NAD+ infusion metabolome pilot Small human IV study; metabolic observations do not prove longevity or everyday benefits.
- Reyna et al. (2026): retrospective IV tolerability pilot Route-specific retrospective tolerability evidence; not proof of effectiveness for home injections.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.